Product Packaging

September 5, 2024

Pharmacologic Treatment Of Obese And Excessive Weight In Grownups Endotext Ncbi Shelf

Pharmacologic Treatment Of Overweight And Obesity In Grownups Endotext Ncbi Shelf Various other representatives like Ozempic (semaglutide) and Mounjaro (tirzepatide) are accepted for blood sugar level control in kind 2 diabetes, however have likewise been recommended "off-label" for weight...

Read more →
September 5, 2024

Tesofensine Anti-obesity Medicine

Brand-new Antiobesity Medicine, Tesofensine, Reveals Excellent Stage Ii Results Nature Testimonials Gastroenterology & Hepatology The pharmacology of psilocybin is certainly regular with effects on feeding behavior. Psilocybin is quickly dephosphorylated in the body by alkaline phosphatase to the...

Read more →
September 5, 2024

Prescription Weight Reduction Medicine: Discovering Therapy Options

Are The Brand-new Weight Reduction Drugs As Well Great To Be True? Semaglutide has been received researches to create a rare type of thyroid lump in animals, however it is not recognized if it can create thyroid cancer cells in individuals. "Which drug makes good sense for a patient is mosting...

Read more →
September 5, 2024

Tesofensine, An Unique Antiobesity Medicine, Silences Gabaergic Hypothalamic Neurons Plos One

Tesofensine Knowledge And Recommendations It displays powerful antiobesity effects, yet the underlying mobile mechanisms are still being proactively examined. This research initially intends to determine the neuronal correlates of tesofensine-induced weight loss in the Lateral Hypothalamus (LH) in...

Read more →
September 5, 2024

Making Use Of A Phenotype-guided Approach For The Therapy Of Excessive Weight

Tesofensine Understanding And References In the United States and Europe, orlistat, naltrexone/bupropion, liraglutide 3 mg and, most recently, semaglutide 2.4 mg are registered and advertised. Additionally, in the USA, phentermine/topiramate is also available for long-term use40. The...

Read more →
Welcome to MediQuest Pharmaceuticals, where innovation meets excellence in the pharmaceutical industry. I am Michael Johnson, the founder and driving force behind MediQuest Pharmaceuticals. With over two decades of experience in drug development and pharmaceutical regulations, I have dedicated my career to advancing healthcare through innovative pharmaceutical solutions. Born and raised in the bustling city of Boston, my fascination with science began at a young age, nurtured by countless hours spent in the local library reading about chemistry and biology. This passion led me to pursue a degree in Medicinal Chemistry at the University of Massachusetts, followed by a Ph.D. in Pharmaceutical Sciences. After completing my education, I ventured into the pharmaceutical industry, where I gained extensive experience in various facets of drug development and manufacturing.